Dublin, County Dublin, Ireland Malin Corporation is the famous Corporate Investor, which was founded in 2014. The fund was located in Europe if to be more exact in Ireland. The main department of described Corporate Investor is located in the Dublin.
Among the most popular fund investment industries, there are Medical, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Xenex, Artizan Biosciences, 3D4Medical.com. The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The real fund results show that this Corporate Investor is 38 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Malin Corporation works on 21 percentage points less the average amount of lead investments. The high activity for fund was in 2015. The higher amount of exits for fund were in 2019. The fund is generally included in 2-6 deals every year. The average startup value when the investment from Malin Corporation is 10-50 millions dollars.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Malin Corporation, startups are often financed by Wellcome Trust, Targeted Technology Fund, RK Ventures Group. The meaningful sponsors for the fund in investment in the same round are Woodford Investment Management, Vivo Capital, Longitude Capital. In the next rounds fund is usually obtained by Vivo Capital, Longitude Capital, Bill & Melinda Gates Foundation.
Related Funds
| Fund Name | Location |
| Acko Technology and Services | - |
| Aquiline Technology Growth | New York, New York, United States |
| BankInvest | Copenhagen, Denmark, Hovedstaden |
| BIG BOOSTER | France, Lyon, Rhone-Alpes |
| Bradley Family Trust | Milwaukee, United States, Wisconsin |
| Capture Investments | - |
| Dahua Technology | Binjiang, China, Jiangxi |
| EVOLEM | - |
| Footpath Ventures | New York, New York, United States |
| Footprint Ventures | Bangalore, India, Karnataka |
| HC2 | Herndon, United States, Virginia |
| Innovation Factory (Canada) | Canada, Hamilton, Ontario |
| Mountain Internet | - |
| One Financial Holdings | New York, New York, United States |
| Raine Ventures | California, San Francisco, United States |
| Shenzhen Chunshang Capital | China, Guangdong, Shenzhen |
| Staffmark | Cincinnati, Ohio, United States |
| Suzuyo & Co | Japan, Shimizu, Shizuoka Prefecture |
| TOTVS | Brazil, São Paulo, Sao Paulo |
| UpAccelerate | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Poseida Therapeutics | $142M | 22 Apr 2019 | San Diego, California, United States | ||
Poseida Therapeutics | $30M | 03 Apr 2018 | San Diego, California, United States | ||
Poseida Therapeutics | $11M | 02 Aug 2017 | San Diego, California, United States | ||
Kymab | $100M | 24 Nov 2016 | England | ||
Poseida Therapeutics | $23M | 23 Dec 2015 | San Diego, California, United States | ||
Kymab | $50M | 06 May 2015 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Poseida Therapeutics | $142M | 22 Apr 2019 | San Diego, California, United States | ||
Poseida Therapeutics | $30M | 03 Apr 2018 | San Diego, California, United States | ||
Poseida Therapeutics | $11M | 02 Aug 2017 | San Diego, California, United States | ||
Kymab | $100M | 24 Nov 2016 | England | ||
Poseida Therapeutics | $23M | 23 Dec 2015 | San Diego, California, United States | ||
Kymab | $50M | 06 May 2015 | England |
